Impact of multi-professional medication reviews (MPMRs) on medication prescriptions in psychiatry
Matthieu Lebrat, Ahava Cohen, Rachel Megard, Nicolas Franck, Claude Dussart, Marion Perin-Dureau · 2026
Read Impact of multi-professional medication reviews (MPMRs) on medication prescriptions in psychiatry by Matthieu Lebrat, Ahava Cohen, Rachel Megard, Nicolas Franck, Claude Dussart, Marion Perin-Dureau (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0358539.txt.
Description
Matthieu Lebrat leads a team of six measuring what happens to prescriptions when a hospital's specialists review them together, in PLOS ONE in 2026. Multi professional medication reviews bring doctors, pharmacists, and nurses around one table to prune drug lists, and psychiatry, where patients often carry heavy sedative loads, had little evidence. The French university hospital study compared stays before and after reviews began across four psychiatric wards, spanning 2017 to 2023.
After reviews started, patients left hospital with about one fewer prescribed drug on average, a small but statistically firm shift. The cuts concentrated where they matter most: psychotropic medicines fell furthest, led by benzodiazepines, with antipsychotics and anticholinergic drugs also down, and even laxatives, often prescribed to counter drug side effects, declined. No drug class rose to compensate. The authors read the pattern as reviews doing quiet, compounding good in a high risk prescribing environment.
Catalog record
| CREATOR | Matthieu Lebrat, Ahava Cohen, Rachel Megard, Nicolas Franck, Claude Dussart, Marion Perin-Dureau |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34301 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |